Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone versus crystalline penicillin for ocular syphilis
RBR-92wcttdPhase 3Recruiting
- Sponsor
- Hospital de Clínicas da Unicamp
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ceftriaxone and benzylpenicillin in syphilis (2 arms), sponsored by Hospital de Clínicas da Unicamp. Started Jan 2025; status: recruiting.
02
Drugs
ceftriaxonebenzylpenicillin
03
Conditions
syphilis
Beyond the preview
Go deeper on RBR-92wcttd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-92wcttd.